ArticleFrontiers in pharmacology2024

Integrating fecal metabolomics and intestinal microbiota to study the mechanism of cannabidiol in the treatment of idiopathic pulmonary fibrosis.

Mengdi Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.